Floxuridine drug data and news

Floxuridine drug data, resources, and news articles (when available). Onconews.org provides news on cancer research. This section, which includes profiles on medicines that may or not be cancer-related is in beta form. If things run smoothly we will be releasing a new format late in the summer of 2006.

Generic name Floxuridine
Brand Names/Synonyms 5 Fluorodeoxyuridine; 5fdu; Deoxyfluorouridine; FDUR; FUDR; Fdurd; Floxiridina [Inn-Spanish]; Floxuridin; Floxuridine; Floxuridine [Usan:Inn]; Floxuridinum [Inn-Latin]; Fluorodeoxyuridine; Fluoruridine Deoxyribose; HSDB 3227; NSC 27640; NSC-26740; NSC-27640
Indication For palliative management of gastrointestinal adenocarcinoma metastatic to the liver, when given by continuous regional intra-arterial infusion in carefully selected patients who are considered incurable by surgery or other means.
Sponsored links
Description Not Available
Pharmacology Floxuridine is a pyrimidine analog that acts as an inhibitor of the S-phase of cell division. This selectively kills rapidly dividing cells. Floxuridine is an anti-metabolite. Anti-metabolites masquerade as pyramidine-like molecules which prevents normal pyrimidines from being incorporated into DNA during the S phase of the cell cycle. Flurouracil (the end-product of catabolism of floxuridine) blacks an enzyme which converts cytosine nucleosides into the deoxy derivative. In addition, DNA synthesis is further inhibited because fluoruracil blocks the incorporation of the thymdine nucleotide into the DNA strand.
Mechanism Of Action Floxuridine is rapidly catabolized to 5-fluorouracil which is the active form of the drug. Fluorouracil inhibits thymydilate synthase leading to inhibition of DNA synthesis, RNA synthesis and cell death.
Floxuridine News
(When available)
Radiation Therapy Improves Outcome of Unresectable Liver Cancer  Dec 5, 2005
Cancerpage.com, NEW YORK DEC 05, 2005 (Reuters Health) - Adding high-dose conformal radiation therapy (RT) to intra-arterial floxuridine improves outcomes in patients with ...

Radiation can help when liver cancer is inoperable  Dec 5, 2005
ABC News Ben-Josef and colleagues treated 128 patients with inoperable liver cancer with high-dose radiation therapy and infusion of the chemo agent floxuridine into an ...

Bile duct cancer, liver cancer, or metastatic colorectal cancer ...  Dec 3, 2005
Xagena.it, In the study, patients received radiation twice daily for two weeks, along with a continuous infusion of the chemotherapy drug Floxuridine ( FUDR ). ...

Dosage Forms POWDER FOR SOLUTION (500mg vial)
Drug_Category Antivirals; Antimetabolites
Absorption Not Available
Interactions Interactions for Floxuridine: Combination Therapy: Any form of therapy which adds to the stress of the patient, interferes with nutrition or depresses bone marrow function will increase the toxicity of Floxuridine.
Toxicity Oral, rat LD50: 215 mg/kg. Signs of overdose include nausea, vomiting, diarrhea, gastrointestinal ulceration and bleeding, and bone marrow depression (including thrombocytopenia, leukopenia and agranulocytosis).
Organisms Affected Not Available
Chemical IUPAC Name 5-fluoro-1-[4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1H-pyrimidine-2,4-dione
Chemical Formula C9H11FN2O5
Molecular Weight 246.193 g/mol
Smiles String C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O
Melting Point 150.5 °C
Water Solubility 1.19E+004 mg/L
State Solid (white powder)
LogP/Hphobicity -1.249
Isoelectric Point 7.44
Biotransformation Hepatic.
Half Life Not Available
Protein Binding [%] Not Available
RxList Link RXlist
Sponsored links
Drug Reference http://www.drugs.com/cons/Floxuridine.html
http://www.rxlist.com/cgi/generic2/floxuridine.htm
Drug Type Approved Drug
Accession No APRD00692
CAS Registry Number 50-91-9
KEGG Compound ID C11736
PubChem ID SID:148580
PharmGKB ID PA449652
SwissProt ID Not Available
GenBank ID Not Available
Drug ID Number [DIN] Not Available

Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org